-
Ferring announces abstract of the first prospective, multi-national, real-world study of Rekovelle® (follitropin delta) at the congress of the Pacific Society for Reproductive Medicine
inFerring announces abstract of the first prospective, multi-national, real-world study of Rekovelle®…
-
Approval of new medicines in 2022 sets Ferring on course for future growth and diversification
inApproval of new medicines in 2022 sets Ferring on course for future…
-
Ferring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer
inFerring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer…
PRESS RELEASE 2023
PRESS RELEASE 2023